0.9759

0.94% -0.0093

Pre-market: .96 -0.0159 -1.63%

Nexalin Technology Inc (NXL)

Overview News Price History Financials Discussions Forecast

Nexalin Technology Inc stock is traded at $0.9759, with a volume of 76,715. It is down -0.94% in the last 24 hours and down -29.28% over the past month. Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

Previous Close:

$0.9852

Open:

$0.9613

24h Volume:

76,715

Relative Volume:

0.02

Market Cap:

$18.20M

Revenue:

$174.80K

Net Income/Loss:

$-8.85M

P/E Ratio:

-1.417

EPS:

-0.6887

Net Cash Flow:

$-4.37M

1W Performance:

-9.64%

1M Performance:

-29.28%

6M Performance:

-21.30%

1Y Performance:

-76.48%

1-Day Range:

$0.9613

$0.991

1-Week Range:

$0.91

$1.0983

52-Week Range:

$0.702

$4.39

Nexalin Technology Inc Stock (NXL) Company Profile

Name

Nexalin Technology Inc

Sector

Healthcare (1131)

Industry

Medical Devices (144)

Phone

(832) 260-0222

Address

1776 YORKTOWN, HOUSTON

Employee

Twitter

Next Earnings Date

2025-12-03

Latest SEC Filings

NXL's Discussions on Twitter

Compare NXL with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
NXL Nexalin Technology Inc	0.9759	18.38M	174.80K	-8.85M	-4.37M	-0.6887
ABT Abbott Laboratories	125.40	217.86B	43.84B	13.90B	6.92B	7.9725
BSX Boston Scientific Corp	97.72	146.12B	19.35B	2.78B	3.82B	1.8696
SYK Stryker Corp	364.35	139.95B	24.38B	2.94B	4.07B	7.6159
MDT Medtronic Plc	101.99	130.73B	34.76B	4.79B	5.21B	3.7017
EW Edwards Lifesciences Corp	85.78	48.73B	5.88B	1.34B	799.60M	2.3489

Nexalin Technology Inc Stock (NXL) Latest News

Dec 04, 2025

Nexalin advances Alzheimer’s device after FDA meeting By Investing.com - Investing.com South Africa

Dec 04, 2025

Nexalin Technology and BioVie Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Pocono Record

Dec 04, 2025

Dec 03, 2025

Nexalin Technology completes FDA Q-submission meeting for Gen-2 Sync - marketscreener.com

Dec 03, 2025

Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC™ Neurostimulation Console in Alzheimer’s Disease Program - Yahoo Finance

Dec 03, 2025

Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4 - markets.businessinsider.com

Dec 03, 2025

How Nexalin Technology Inc. stock trades before earnings2025 Trading Recap & Risk Controlled Stock Alerts - Newser

Dec 03, 2025

Will Nexalin Technology Inc. Equity Warrant stock reach Wall Street targetsWatch List & Long Hold Capital Preservation Plans - Newser

Dec 03, 2025

Dec 02, 2025

Nexalin Technology earnings missed by $0.01, revenue fell short of estimates - Investing.com Canada

Dec 02, 2025

Nov 28, 2025

Volume Summary: Is Nexalin Technology Inc. Equity Warrant stock supported by strong cash flows2025 Technical Patterns & Smart Swing Trading Alerts - BỘ NỘI VỤ

Nov 28, 2025

Nov 27, 2025

Investors in cash trouble should check out Nexalin Technology Inc (NXL) - Setenews

Nov 27, 2025

Nov 24, 2025

Nexalin Technology (NASDAQ:NXL) Rating Lowered to Sell at Wall Street Zen - Defense World

Nov 24, 2025

Nov 22, 2025